Skip to the main content

Acta clinica Croatica, Vol. 60. No. 3., 2021.

Preliminary communication

https://doi.org/10.20471/acc.2021.60.03.26

Antiplatelet Therapy after Coronary Artery Bypass Graft Surgery – Unevenness of Daily Clinical Practice

Ivana Sopek Merkaš ; Krapinske Toplice Special Hospital for Medical Rehabilitation, Krapinske Toplice, Croatia
Nenad Lakušić ; Krapinske Toplice Special Hospital for Medical Rehabilitation, Krapinske Toplice, Croatia; Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia; Faculty of Dental Medicine and Health in Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Krunoslav Fučkar ; Krapinske Toplice Special Hospital for Medical Rehabilitation, Krapinske Toplice, Croatia; Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Duško Cerovec ; Krapinske Toplice Special Hospital for Medical Rehabilitation, Krapinske Toplice, Croatia; Faculty of Medicine in Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
Kristina Marić Bešić ; Zagreb University Hospital Centre, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia

Full text: english pdf 206 Kb

page 540-543

downloads: 422

cite

Abstract

Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients
with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted
(combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute
coronary syndrome with percutaneous coronary intervention, chronic coronary syndrome, or coronary
surgical revascularization) and comorbidity of each patient (e.g., atrial fibrillation, left ventricular
thrombus, etc.). Guidelines and clinical practice in particular are not uniform and specific regarding
dual antiplatelet therapy in patients undergoing coronary artery bypass grafting, especially in the setting
of chronic coronary syndrome.

Keywords

Antiplatelet therapy; Coronary artery disease; Coronary artery bypass grafting

Hrčak ID:

271694

URI

https://hrcak.srce.hr/271694

Publication date:

1.9.2021.

Article data in other languages: croatian

Visits: 1.364 *